SCHEMBL7379913

SCHEMBL7379913

CCc1nc2c[nH]nc2c(=O)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS2 Q9H2K2 1/20 0.50
▸ ADORA3 P0DMS8 3/20 0.47
▸ DDAH1 O94760 1/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ GAA P10253 4/20 0.38
▸ HTT P42858 1/20 0.38
▸ HPGD P15428 1/20 0.37
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ SRC P12931 1/20 0.35
▸ ACVR1 Q04771 1/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22118823 0.83 KDM4E (0.42) TNKS2ADORA3ALDH1A1HTTADORA2A
SCHEMBL7420122 0.81 CACNA1H (0.37) TNKS2ADORA3ALDH1A1GAAADORA2A
SCHEMBL7422513 0.79 ADORA3 (0.33) TNKS2ADORA3GAAKDM4E
SCHEMBL22118927 0.77 ADORA3 (0.33) TNKS2ADORA3GAAKDM4ENPC1
SCHEMBL14281548 0.77 PARP1 (0.46) TNKS2ADORA3ALDH1A1GLAGAA
SCHEMBL7416792 0.74 KDM4E (0.32) ALDH1A1KDM4EPARP1KDM4CSMN1; SMN2
SCHEMBL22119325 0.74 CYP1A2 (0.32) L3MBTL1KDM4E
SCHEMBL19236511 0.73 MITF (0.47) TP53ALDH1A1GLAKDM4EMAPT
SCHEMBL7350550 0.72 KMT2A (0.40) ADORA3GAAACVR1KDM4CMAPT
SCHEMBL7348346 0.72 PNP (0.47) ADORA3ALDH1A1GLAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0977756-A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2000-02-09 — — EP disclosed
WO-1998049166-A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 1998-11-05 — — WO disclosed
Send feedback